UK judge to rule on foreign patent infringement

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

UK judge to rule on foreign patent infringement

A judge sitting in the High Court in London has said he can rule on whether patents in France, Germany, Italy and Spain are infringed in a single trial in the UK

In a dispute between Actavis and Eli Lilly, Mr Justice Arnold this week accepted Actavis’s submission that there were good reasons to hear all the related infringement cases in the England & Wales court.

[I]n my judgment Lilly has not shown that the courts of France, Germany, Italy and Spain are the appropriate fora for the trial of Actavis’ claims in relation to the French, German, Italian and Spanish designations of the Patent. Certainly I do not consider that it has shown that those courts are clearly or distinctly more appropriate than this Court. Accordingly, I would decline to grant a stay of those claims on the grounds of forum non conveniens,” said the judge.

The dispute concerns the national designations of Eli Lilly’s European patent 1 313 508 for the use of pemetrexed disodium. Actavis seeks a declaration that it can produce pemetrexed dipotassium without infringing the patents .

Eli Lilly sells its version of the drug as a cancer treatment using the brand Alimta.

The opportunity for courts to rule on the infringement of foreign IP rights was opened up by the UK Supreme Court’s copyright decision in Lucasfilm v Ainsworth last year. Arnold argued in his judgment that patent rights should essentially be treated the same as copyright.

According to Lucasfilm, UK courts cannot rule on the validity of foreign IP rights.

In this case, Actavis deliberately did not ask the court to rule on the (in)validity of the patent. However, it is a party to opposition proceedings at the EPO in which the validity is challenged. As Arnold said parenthetically: “In effect, therefore, the Actavis group has voluntarily bifurcated the infringement and validity aspects of its case with respect to the Patent .”

Bifurcation of validity and infringement proceedings is common in Germany, but not in the UK and is in fact criticised by many UK practitioners.

Actavis is represented by Bird & Bird, Richard Meade QC and Thomas Raphael and Eli Lilly by Hogan Lovells, Stephen Phillips QC and Thomas Mitcheson. Bird & Bird has published an article analysing the ruling.

Eli Lilly is expected to appeal the decision to the Court of Appeal. If the decision is upheld, the judge will have to hear evidence and then rule on whether the various patents are infringed by Actavis’s proposed activities. The company wants to enter the market by the end of 2015.

more from across site and SHARED ros bottom lb

More from across our site

Nigel Stoate, head of Taylor Wessing's award-winning UK patents team, tells us about his team’s UPC successes and why collaboration is king
Camilla Balleny, who spent a decade at Carpmaels & Ransford, will become the firm’s first head of patent litigation, Managing IP can reveal
Leaders at the newly merged firm Jones Maxwell Smith & Davis reveal their plan to take on bigger firms while attracting more clients and talent
Charles Achkar, who will bring a team of two with him, said he was excited about joining ‘one of the few strong IP boutiques’
Andy Lee, head of IP at Brandsmiths and winner of the Soft IP Practitioner of the Year award, tells us why 2024 was a seminal year and why clients value brave advice
The deal to acquire MIP's parent company is expected to complete by the end of May 2025
Jinwon Chun discusses the need for vigilance, his love for iced coffee, and preparing for INTA
Karl Barnfather’s new patent practice will focus on protecting and enforcing tech innovations in the electronics, AI, and software industries
Partner Ranjini Acharya explains how her Federal Circuit debut resulted in her convincing the court to rule that machine learning technology was not patent-eligible
Paul Hastings and Smart & Biggar also won multiple awards, while Baker McKenzie picked up a significant prize
Gift this article